Affiliation:
1. Zeenat Qureshi Stroke Research Center, Department of Neurology and Neurosciences, and The Carotid Revascularization Endarterectomy versus Stent Trial Investigators, University of Medicine and Dentistry of New Jersey, Newark, New Jersey
2. Zeenat Qureshi Stroke Research Center, Department of Neurology and Neurosciences, University of Medicine and Dentistry of New Jersey, Newark, New Jersey
3. The Carotid Revascularization Endarterectomy versus Stent Trial Investigators, University of Medicine and Dentistry of New Jersey, Newark, New Jersey
Abstract
Abstract
OBJECTIVE:
Carotid angioplasty with or without stent placement (CAS) has been proposed as an alternative method to carotid endarterectomy (CEA) for treatment of carotid stenosis. Small randomized trials have evaluated the comparative efficacy of both methods; however, definitive evidence is lacking.
METHODS:
A search was made for randomized clinical trials comparing CAS and CEA for treatment of carotid stenosis. A literature search of MEDLINE, PubMed, and Cochrane databases was supplemented by a review of bibliographies of relevant articles and personal files. A meta-analysis was performed using a random effects model because significant heterogeneity was observed. Outcomes compared included 1-month composite rates of stroke or death, all strokes, disabling strokes, myocardial infarction, cranial nerve injury, and major bleeding and 1-year rates of both minor and major ipsilateral strokes.
RESULTS:
We analyzed five randomized trials totaling 1154 patients (577 randomized to CEA and 577 randomized to CAS). The composite end point of 1-month stroke or death rate was not different between patients treated with CAS compared with those treated with CEA (relative risk [RR], 1.3; 95% confidence interval [CI], 0.6–2.8; P = 0.5). The 1-month stroke rate (831 patients analyzed: RR, 1.3; 95% CI, 0.4–3.6; P = 0.7) and disabling stroke rate (831 patients analyzed: RR, 0.9; 95% CI, 0.2–3.5; P = 0.9) was similar for CAS and CEA. The 1-month rates of myocardial infarction (814 patients analyzed: RR, 0.3; 95% CI, 0.1–0.9) and cranial nerve injury (918 patients analyzed: RR, 0.05; 95% CI, 0.01–0.3) were significantly lower for CAS. No significant differences were observed in 1-year rates of ipsilateral stroke (814 patients analyzed: RR, 0.8; 95% CI, 0.5–1.2; P = 0.2).
CONCLUSION:
The 30-day stroke and death rates associated with CAS and CEA were not significantly different. Lower rates of myocardial infarction and cranial nerve injury were observed with CAS compared with CEA.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Neurology (clinical),Surgery
Reference60 articles.
1. Use of the Parodi anti-embolism system in carotid stenting: Italian trial results;Adami;J Endovasc Ther,2002
2. Results of a multicenter prospective randomized trial of carotid stenting versus carotid endarterectomy;Alberts;Stroke,2001
3. Schneider WALLSTENT Endoprosthesis Clinical Investigators: A randomized clinical trial of carotid stenting versus endarterectomy in patients with symptomatic carotid stenosis—Study design;Alberts;J Neurovasc Dis,1997
4. Multicenter evaluation of carotid artery stenting with a filter protection system;Al-Mubarak;J Am Coll Cardiol,2002
5. Study design for randomized prospective trial of carotid endarterectomy for asymptomatic atherosclerosis;Asymptomatic Carotid Atherosclerosis Study Group;Stroke,1989
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献